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Abstract 
This study discusses the effect and clinical significance of fast‑track surgery (FTS) combined with laparoscopic radical 
surgery on the plasma level of vascular endothelial growth factor (VEGF) in locally advanced gastric antrum cancer. 
Plasma VEGF levels were detected in 63 cases of locally advanced gastric antrum cancer by using double‑antibody 
sandwich Avidinbiotincomplex‑ELISA before and after operation. The pure laparoscopic surgery group (group A) 
comprised 30 cases, and the combined FTS group (group B) consisted of 33 cases. Results of the two groups were 
obtained at similar time points and then compared. The VEGF levels were not significantly different between the 
two groups on the first day before the operation and on the first day, third day, and sixth month after the operation 
(P > 0.05). However, the differences were significant on the seventh day and first month after the operation (P < 0.05). 
The postoperative eating time, anal exhaust time, and hospital stay of the patients were statistically significantly dif‑
ferent between the two groups (P < 0.05). Nevertheless, no significant differences were detected in terms of wound 
healing time and complications (P > 0.05). The 3‑year survival rate significantly differed between the two groups 
(P < 0.05). FTS combined with laparoscopic surgery can decrease the postoperative VEGF level compared with pure 
laparoscopic surgery. The combined approach improved postoperative recovery without prolonging the wound heal‑
ing time or increasing the incidence of postoperative complications. The 3‑year survival rate also increased. Thus, FTS 
combined with laparoscopic surgery can improve the prognosis in gastric antrum cancer.
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Background
Gastric cancer is a prevalent malignant cancer worldwide 
and ranks second among all cancers in terms of mortality 
(Parkin et  al. 2005). Surgery is the commonly used and 
the most effective approach for treatment of gastric can-
cer. In recent years, laparoscopic surgery has provided 
a new solution to gastric cancer treatment. Goh et  al. 
(2001) first reported treatment of advanced gastric can-
cer by using laparoscopic D2 radical gastrectomy in 1997. 
The safety and feasibility of this approach have been rec-
ognized by many scholars.
Postoperative recovery involves the synergism of various 
factors. Wilmore et  al. (Wilmore and Kehlet 2001; Kehlet 
and Wilmore 2002) proposed the concept of fast-track sur-
gery (FTS) in 2001; FTS aims to adopt optimized measures 
for perioperative treatment by resorting to evidence-based 
medicine. FTS can facilitate postoperative recovery by 
reducing postoperative physical and psychological stresses. 
During recovery and repair of cells and tissues, vascular 
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endothelial growth factor (VEGF) is an important fac-
tor that regulates angiogenesis. VEGF plays a crucial role 
in wound healing by inducing neoangiogenesis, promot-
ing collagen deposition, and stimulating epithelization 
(Bao et  al. 2009; Barrientos et  al. 2008). VEGF also pro-
vides oxygen and nutrition for tumor growth, infiltration, 
and metastasis. Reports showed (Belizon et  al. 2008) that 
laparoscopic surgery decreases the increasing amplitude of 
postoperative VEGF and the probability of recurrence. Nev-
ertheless, whether FTS combined with laparoscopic surgery 
can inhibit the increasing postoperative VEGF level, facili-
tate postoperative recovery, and improve survival without 
increasing the incidence of complications or wound heal-
ing time remains debatable. To elucidate the effect of FTS, 
scholars have compared the outcome of patients with locally 
advanced gastric antrum cancer after pure laparoscopic sur-
gery or laparoscopic surgery combined with FTS. Changes 
in the plasma VEGF levels are regularly monitored to assess 
the influence of FTS combined with laparoscopic surgery on 
postoperative VEGF levels and on the prognosis. Research 
results are reported in this article.
Patients and methods
General information
We recruited 63 cases of locally advanced gastric antrum 
cancer admitted to our hospital (31 males and 32 females, 
aged 46–73  years old) from January 2009 to October 
2011. Of these cases, 56 patients were Han, and seven 
patients were minority. Approval was obtained from the 
hospital ethics committee, and informed consent was 
signed by all patients. The general information of the two 
groups of patients showed no statistically significant dif-
ference (P > 0.05, Table 1).
Inclusion and exclusion criteria
Inclusion criteria: pathologically confirmed as adenocar-
cinoma before surgery; no distant metastasis found in 
imaging and laboratory examinations; no serious func-
tional disorder of major organs with surgical tolerance; 
and belong to the T2 or T3 stage by preoperative clinical 
staging. Exclusion criteria: received neoadjuvant chemo-
therapy; presented multiple primary gastric cancers; 
found with distant metastasis through intraoperative 
examination; and presence of bleeding, obstruction, and 
perforation requiring emergency rescue.
Laparoscopic surgery and FTS
All surgeries were performed by the same group of sur-
geons. Conventional five-incision method was used. 
Pneumoperitoneum was established with pressure rang-
ing from 12 to 14  mmHg, and a 10-mm Trocar and a 
laparoscope was successively inserted. For all patients, (1) 
D2 radical gastrectomy was performed; (2) en bloc exci-
sion was performed along the paratumor tissues; (3) and 
tumor-free principle was followed. For the combined FTS 
group, additional treatment measures were administered. 
Preoperative education and nutrition support therapy 
were enhanced. The postoperative fasting time was short-
ened. The nutrition canal was indwelled by 20–30  cm 
from the distal end of the anastomotic stoma. Insulation 
was also conducted, and 5-hydroxytryptamine recep-
tor antagonist was given to relieve nausea and vomit-
ing. Patients also started eating and moving around at an 
earlier time. Sufficient analgesic measures were further 
provided. The following conventional recovery meas-
ures were administered in the control group: normal diet 
before operation, preoperative fasting for 6–8 h; only the 
gastric tube was indwelled; the patient was not allowed 
to eat until the first anal exhaust; and targeted analgesics 
were provided according to the need of patients.
Statistical method
SPSS 13.0 software was used. Attribute data were ana-
lyzed using χ2 test, and variable data were expressed as 
X  ±  S. Pearson’s correlation was calculated to compare 
the differences in the VEGF levels. Repeated measure 
analysis of variance was applied to compare the VEGF lev-
els obtained at the same time points. A test for spherical 
Table 1 General clinical data of the two groups of patients with gastric antrum cancer
Item Group A Group B P value
Sex (male/female) 16/14 15/18 0.53
Age (years) 61.53 ± 12.37 61.12 ± 12.46 0.83
Ethnic (Han/minority) 27/3 29/4 0.79
Preoperative complication (yes/no) 13/17 14/19 0.94
Surgical approach (Billorth I/Billorth II) 12/18 17/16 0.36
Pathological type
Mucinous adenocarcinoma, signet ring cell carcinoma and undifferentiated adenocarcinoma 11 13 0.82
Highly/moderately differentiated adenocarcinoma 19 20
Type of tumor (protruded type/ulcerative type) 14/16 12/21 0.41
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symmetry was also performed (if the spherical symmetry 
hypothesis was null, Greenhouse–Geisser correction was 
performed). Kaplan–Meier single-factor analysis was con-
ducted to compare the cumulative survival rate and the 
average survival time within 1–3 years after the operation. 
The significance level was set as α = 0.05.
VEGF detection
Double-antibody sandwich ABC-ELISA was conducted. 
A VEGF-ELISA assay kit was purchased from Jingmei 
Biotech Co., Ltd. The procedures were performed in 
accordance to the instruction manual. Peripheral blood 
samples were collected from the patients in the morning 
on the first day before the operation and on the first day, 
third day, seventh day, first month, and sixth month after 
the operation. The plasma VEGF levels in the two groups 
were detected and compared.
Follow‑up
From the day of the surgery to December 2014, 59 cases 
were followed up and four cases were lost. The follow-
up rate was 93.65  % (59/63), and the median follow-up 
time was 37.1  months. For the cases lost to follow-up, 
examination results on the last follow-up were used for 
statistical calculation. Data of the patients completely 
lost to follow-up and patients died for reasons other than 
the tumor were treated as truncated data. Chest X-ray, 
abdominal B ultrasound, and tumor-related antigen 
detection were performed every month within 6 months 
after the operation. Fibrogastroscopy and CT examina-
tion were conducted every 4–6 months.
Results
Comparison of surgical conditions and postoperative 
recovery
All patients successfully underwent laparoscopic surgery. 
The postoperative hospital stay was shortened in the com-
bined FTS group compared with that in the pure lapa-
roscopic group (18.5 ±  5.5 vs. 11.0 ±  2.0); the first anal 
exhaust time (4.0 ± 1.0 vs. 2.5 ± 0.5) and the postopera-
tive eating time were statistically significantly earlier than 
those in the pure laparoscopic group (P < 0.05). No signif-
icant differences were further observed in terms of opera-
tion time, intraoperative bleeding volume, perioperative 
blood transfusion, postoperative complications, wound 
healing time, postoperative T staging and postoperative N 
staging (P > 0.05). In the pure laparoscopic group (group 
A), one case presented pulmonary infection, and one case 
presented with delayed gastric emptying. In the combined 
FTS group, one case demonstrated urinary tract infec-
tion and one case with subcutaneous emphysema. The 
two groups did not significantly differ in terms of the inci-
dence of complications (P > 0.05, Table 2).
Comparison of plasma VEGF
On the first day before the operation and on the first day, 
third day, sixth day, and sixth month after the operation, 
the VEGF levels were not significantly different between 
the two groups (P > 0.05). Statistically significant differ-
ences were detected on the seventh day and first month 
after the operation (P < 0.05, Table 3).
Postoperative follow‑up
All patients underwent postoperative XELOX scheme 
chemotherapy 6 cycles. Kaplan–Meier analysis revealed 
that the 1-year cumulative survival rate was not statisti-
cally significantly different between groups A (86.60  %) 
and B (89.10  %) (P  >  0.05). Nevertheless, the 3-year 
cumulative survival rate was significantly differed 
between groups A (48.30 %) and B (54.90 %) (P < 0.05). 
Moreover, the median survival time was statistically sig-
nificantly different between groups A (26.11 months) and 
B (30.59 months) (P < 0.05, Fig. 1).
Table 2 Postoperative conditions of  the two groups 
of patients
a Median for skewedly distributed data
Item Group A Group B P value







Time of first anal exhaust 
(days)
4.0 ± 1.0 2.5 ± 0.5 0.03
Time for wound healing 
(days)
10.0 ± 1.0 11.5 ± 1.5 0.29
Postoperative eating time 
(days)




Postoperative hospital stay 
(days)
18.5 ± 5.5 11.0 ± 2.0 0.00
pT1–2/pT3 9/21 11/22 0.78
pN0–1/pN2 14/16 18/15 0.53
Table 3 Comparison of  VEGF levels of  the two groups 
before and after operation (X ± S) pg/ml
Item Group A Group B P value
Day 1 before operation 47.27 ± 34.17 47.51 ± 33.76 1.00
Day 1 after operation 54.38 ± 24.81 53.27 ± 23.96 0.94
Day 3 after operation 62.73 ± 25.13 59.18 ± 24.89 0.86
Day 7 after operation 79.93 ± 27.36 64.36 ± 28.14 0.04
1 month after operation 47.28 ± 28.15 36.67 ± 25.12 0.03
6 months after operation 36.32 ± 25.31 35.4 8 ± 24.95 0.85
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Discussion
Surgeons primarily aim to reduce surgical trauma and 
facilitate postoperative recovery. Minimally invasive sur-
gery can effectively reduce surgical trauma and intraop-
erative bleeding and produce smaller wounds, resulting 
in fast postoperative recovery. Nevertheless, less surgical 
trauma is insufficient, and scholars also focus on facili-
tating postoperative recovery. Currently, many proven 
measures are used preoperatively, intraoperatively, and 
postoperatively to reduce stress responses and relevant 
complications, thus improving the perioperative condi-
tion of patients. The combination of various therapies 
exhibits high effectiveness in relieving pain and facilitat-
ing postoperative recovery. In this study, the following 
additional measures were performed in the combined 
FTS group: preoperative education and nutrition sup-
port therapy were enhanced; the postoperative fasting 
time was shortened; the nutrition canal was indwelled by 
20–30 cm from the distal end of the anastomotic stoma; 
insulation was conducted, and 5-hydroxytryptamine 
receptor antagonist was given to relieve nausea and vom-
iting; the patients started eating and moving around at 
an earlier time; and sufficient analgesic measures were 
administered. The results showed that patients in the 
combined FTS group presented a shortened postopera-
tive hospital stay and earlier time of the first anal exhaust 
and postoperative eating. The differences were statisti-
cally significant (P < 0.05), which is consistent with previ-
ous reports (Soop et al. 2004; Correia and da Silva 2004; 
Lewis et al. 2001). FTS combined with laparoscopic radi-
cal surgery for treatment of gastric antrum cancer further 
relieved the stress responses, promoted the postoperative 
gastrointestinal recovery, and shortened the hospital stay.
VEGF is the most effective angiogenic factor that has 
been discovered. VEGF promotes the proliferation of 
endothelial cells and vascular leakage. VEGF also specifi-
cally induces the formation of lymphatic vessels and pro-
motes collagen deposition and epithelization. Therefore, 
VEGF plays an important role in wound healing (Kigure 
et al. 2013; Wang et al. 2013). Organisms produce stress 
responses after trauma, leading to increased plasma 
VEGF levels, which play a role in wound healing and in 
reducing the leakage of anastomotic stoma. These post-
operative stress responses can be effectively mitigated by 
FTS through decreasing the VEGF level. This research 
aimed to determine whether FTS affects wound heal-
ing and increases the incidence of complications. Our 
results indicated that the VEGF levels of patients in the 
two groups did not show significant difference on the 
first day before the operation and on the first day, third 
day, and sixth month after the operation (P > 0.05). On 
the seventh day and first month after the operation, the 
VEGF level in the combined FTS group decreased com-
pared with that in the pure laparoscopic surgery group 
(P  <  0.05). No differences were observed in the wound 
healing time and incidence of complications between 
the two groups (P > 0.05). Furthermore, the VEGF level 
in the combined FTS group was lower than that in the 
pure laparoscopic surgery group. FTS combined with 
laparoscopic surgery can facilitate postoperative recov-
ery without affecting wound healing and postoperative 
complications in gastric antrum cancer. These results are 
consistent with those reported by Lordache et al. (2010).
Survival rate is an important indicator to evaluate the 
efficacy of therapies for malignant tumors and has also 
been an intensively researched topic. During the course 
of gastric cancer progression, lymph node metastasis is 
among the earliest signs of tumor cell dissemination. By 
promoting the proliferation of vascular endothelial cells 
and enhancing vascular permeability, VEGF induces tumor 
angiogenesis and the formation of lymphatic vessels. Thus, 
VEGF plays a crucial role in the growth and metastasis of 
gastric cancer (Wu et al. 2013; Feng et al. 2011). In surgi-
cal treatment of gastric cancer, the growth and spread of 
tumor cells can be inhibited by decreasing VEGF expres-
sion; nevertheless, the positive effect of this phenomenon 
remains debatable in terms of the recurrence, growth, and 
metastasis of gastric cancer and in decreasing the mortal-
ity by relieving stress responses and trauma. In this study, 
FST combined with laparoscopic radical surgery was used 
to treat gastric antrum cancer. The changes in the plasma 
VEGF level were monitored in locally advanced gastric 
cancer and then compared with the results obtained from 
pure laparoscopic surgery. The two groups showed an 
increasing VEGF level after operation until VEGF reached 
the peak. Subsequently, VEGF level decreased. The VEGF 
Fig. 1 Three‑year survival curves of the two groups
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level increased with low amplitudes in the combined FTS 
group compared with that in the pure laparoscopic surgery 
group. The differences were statistically significant on the 
seventh day and first month after the operation (P < 0.05). 
Kaplan–Meier analysis showed that the 1-year cumulative 
survival rate was not significantly different between groups 
A (86.60 %) and B (89.10 %) (P > 0.05). Moreover, the 3-year 
cumulative survival rate was significantly different between 
groups A (48.30 %) and B (54.90 %) (P < 0.05). The median 
survival time was also significantly different between 
groups A (26.11 months) and B (30.59 months) (P < 0.05). 
The 3-year survival rates of patients with gastric antrum 
cancer increased by decreasing the VEGF level, which is 
consistent with previous reports (Weich et al. 2004; Tsut-
sumi et al. 2005; Al-Moundhri et al. 2008; He et al. 2008). 
Hence, the plasma VEGF level in gastric antrum cancer is 
significantly related to its prognosis. The VEGF level can be 
used as a suitable predictor of prognosis and as a reference 
to develop treatment regimens for gastric cancer.
In conclusion, FTS combined with laparoscopic radical 
surgery for gastric antrum cancer can effectively reduce 
stress responses and postoperative VEGF levels through 
the following measures: enhancing preoperative educa-
tion and nutrition support therapy, shortening the time 
of preoperative fasting, indwelling the nutrition canal, 
sufficient insulation and analgesic treatment, earlier 
postoperative eating and moving around, relieving the 
psychological burden, and improving the postoperative 
gastrointestinal function and nutrition state.
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